Analyst Research

Report Title Price
Provider: S&P Capital IQ Quantitative Report
Provider: Pechala's Reports
Provider: Pechala's Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aceto Corp's Rising Pharmaceuticals Inc Announces To Launch Generic Version Of Cleocin Pediatric

Monday, 26 Nov 2012 09:49am EST 

Aceto Corp's Rising Pharmaceuticals Inc. announced that it has launched the generic version of the 75mg/5mL strength of Clindamycin Palmitate Hydrochloride for Oral Solution, USP (Pediatric), an FDA approved generic version of Pfizer Inc.'s Cleocin Pediatric. According to IMS Health data, U.S. market sales for Clindamycin Palmitate Hydrochloride, which is an antibiotic that is used to treat serious infections caused by bacteria, were approximately $59 million for the twelve months ended June 30, 2012. 

Company Quote

-0.07 -0.41%
11 Jul 2014